sb 203580 has been researched along with phenylephrine in 17 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (phenylephrine) | Trials (phenylephrine) | Recent Studies (post-2010) (phenylephrine) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 13,797 | 857 | 2,083 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.76) | 18.2507 |
| 2000's | 12 (70.59) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glembotski, CC; Hanford, DS; McDonough, PM; Thuerauf, DJ; Zechner, D | 1 |
| Clerk, A; Lazou, A; Sugden, PH | 1 |
| Aoki, H; Izumo, S; Richmond, M; Sadoshima, J | 1 |
| Babu, GJ; Lalli, MJ; Periasamy, M; Sadoshima, J; Sussman, MA | 1 |
| Giasson, E; Houle, F; Huot, J; Landry, J; Marceau, F; Meloche, S | 1 |
| Hirasawa, A; Itoh, H; Kaziro, Y; Miyamoto, Y; Shinoura, H; Tsujimoto, G; Yamauchi, J | 1 |
| Bogoyevitch, MA; Long, CS; Ng, DC | 1 |
| Lazou, A; Markou, T | 1 |
| Aggeli, IK; Beis, I; Gaitanaki, C; Lazou, A | 1 |
| Galiñanes, M; Hassouna, A; Loubani, M | 1 |
| Chalothorn, D; Faber, JE; Jackson, LF; Lee, DC; Zhang, H | 1 |
| Kwan, YW; Ngai, SM; Seto, SW | 1 |
| Crisostomo, PR; Meldrum, DR; Morrell, ED; Tsai, BM; Wang, M | 1 |
| Hayashi, Y; Nguyen, SV; Nguyen, TM; Purdy, RE; Summers, SM | 1 |
| Caldwell, RB; Caldwell, RW; Carneiro, ZN; Chandra, S; Inscho, EW; Romero, MJ; Shatanawi, A; Toque, HA; Tostes, RC; Webb, RC | 1 |
| Campos-Toimil, M; Cuíñas, A; Elíes, J; Orallo, F | 1 |
| Feng, X; Gao, S; Liu, P; Liu, Z; Wang, J; Xu, S | 1 |
17 other study(ies) available for sb 203580 and phenylephrine
| Article | Year |
|---|---|
A role for the p38 mitogen-activated protein kinase pathway in myocardial cell growth, sarcomeric organization, and cardiac-specific gene expression.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Cardiomegaly; Cell Division; Cell Size; Cells, Cultured; Enzyme Inhibitors; Gene Expression Regulation; Imidazoles; MAP Kinase Kinase 6; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Pyridines; Rats; Sarcomeres | 1997 |
Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart.
Topics: Adrenergic alpha-Agonists; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Enzyme Activation; Heart; Imidazoles; Intracellular Signaling Peptides and Proteins; JNK Mitogen-Activated Protein Kinases; Male; Mitogen-Activated Protein Kinases; Myocardial Ischemia; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Reperfusion; Tetradecanoylphorbol Acetate | 1998 |
Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Topics: Angiotensin II; Animals; Animals, Newborn; Cardiomegaly; Cells, Cultured; Enzyme Inhibitors; Heart; Heart Ventricles; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Models, Cardiovascular; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; Recombinant Proteins; Signal Transduction; Transfection | 2000 |
Phosphorylation of elk-1 by MEK/ERK pathway is necessary for c-fos gene activation during cardiac myocyte hypertrophy.
Topics: Adrenergic alpha-Agonists; Animals; Animals, Newborn; Blotting, Western; Cardiomegaly; Cell Nucleus; Cells, Cultured; Cytosol; DNA-Binding Proteins; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; ets-Domain Protein Elk-1; Flavonoids; Genes, Reporter; Imidazoles; MAP Kinase Kinase 1; Microscopy, Confocal; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Myocardium; Nuclear Proteins; Phenylephrine; Phosphorylation; Plasmids; Promoter Regions, Genetic; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Sprague-Dawley; Serum Response Factor; Time Factors; Transcription Factors; Transfection | 2000 |
p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle.
Topics: Angiotensin II; Animals; Aorta; Aorta, Thoracic; Calcium; Cells, Cultured; Egtazic Acid; Enzyme Inhibitors; Heat-Shock Proteins; HSP27 Heat-Shock Proteins; Imidazoles; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Mitogen-Activated Protein Kinases; Muscle Contraction; Muscle, Smooth, Vascular; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphorylation; Protein Serine-Threonine Kinases; Pyridines; Rats; Reactive Oxygen Species; Signal Transduction; Time Factors; Vasoconstriction | 2000 |
Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in alpha1B-adrenergic receptor/Galphaq-induced inhibition of cell proliferation.
Topics: Adrenergic alpha-Agonists; Butadienes; Cell Count; Cell Division; Cell Line; DNA, Recombinant; Enzyme Inhibitors; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Plasmids; Pyridines; Receptors, Adrenergic, alpha-1; Transfection | 2001 |
A role for the extracellular signal-regulated kinase and p38 mitogen-activated protein kinases in interleukin-1 beta-stimulated delayed signal tranducer and activator of transcription 3 activation, atrial natriuretic factor expression, and cardiac myocyte
Topics: Acute-Phase Proteins; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cell Nucleus; Cells, Cultured; Culture Media, Serum-Free; Cycloheximide; DNA-Binding Proteins; Enzyme Inhibitors; Flavonoids; Growth Inhibitors; Heart; Heart Ventricles; Hypertrophy; Imidazoles; Interleukin-1; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Kinetics; Leukemia Inhibitory Factor; Lymphokines; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphorylation; Protein Transport; Pyridines; Rats; Rats, Sprague-Dawley; STAT3 Transcription Factor; Trans-Activators | 2001 |
Phosphorylation and activation of mitogen- and stress-activated protein kinase-1 in adult rat cardiac myocytes by G-protein-coupled receptor agonists requires both extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase.
Topics: Adrenergic alpha-Agonists; Animals; Calcium-Calmodulin-Dependent Protein Kinases; Endothelin-1; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Heart; Imidazoles; Indoles; Male; Maleimides; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphorylation; Pyridines; Rats; Rats, Wistar; Receptors, Cell Surface; Ribosomal Protein S6 Kinases, 90-kDa | 2002 |
Alpha(1)- and beta-adrenoceptor stimulation differentially activate p38-MAPK and atrial natriuretic peptide production in the perfused amphibian heart.
Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Agonists; Animals; Atrial Natriuretic Factor; Blotting, Western; Electrophoresis, Polyacrylamide Gel; Enzyme Activation; Imidazoles; Immunohistochemistry; Isoproterenol; Mitogen-Activated Protein Kinases; Myocardium; p38 Mitogen-Activated Protein Kinases; Perfusion; Phenylephrine; Phosphorylation; Pyridines; Rana ridibunda; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta | 2002 |
Delayed preconditioning of the human myocardium: signal transduction and clinical implications.
Topics: Acetylcholine; Aged; Alkaloids; Anisomycin; Antihypertensive Agents; Benzophenanthridines; Culture Techniques; Decanoic Acids; Diazoxide; Enzyme Activation; Enzyme Inhibitors; Female; Heart Atria; Humans; Hydroxy Acids; Imidazoles; Ischemic Preconditioning, Myocardial; Male; Middle Aged; Mitogen-Activated Protein Kinases; Myocardial Ischemia; Myocardium; p38 Mitogen-Activated Protein Kinases; Phenanthridines; Phenylephrine; Potassium Channel Blockers; Potassium Channels; Protein Kinase C; Pyridines; Signal Transduction; Tetradecanoylphorbol Acetate; Time Factors | 2004 |
Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Anthracenes; Aorta, Thoracic; Bacterial Proteins; Benzopyrans; Butadienes; Catheterization; Cell Division; Dipeptides; ErbB Receptors; Flavonoids; Glycine; Hydroxamic Acids; Imidazoles; MAP Kinase Kinase 1; MAP Kinase Kinase 2; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitriles; Organ Culture Techniques; Phenylephrine; Phosphorylation; Protein Processing, Post-Translational; Pyridines; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Thrombin; Tyrphostins | 2004 |
Modulatory effect of interleukin-1beta on rat isolated basilar artery contraction.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-Antagonists; Animals; Basilar Artery; Calcium-Calmodulin-Dependent Protein Kinases; Cyclohexenes; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Imidazoles; In Vitro Techniques; Interleukin-1; Male; Monoterpenes; Phenylephrine; Prazosin; Protoporphyrins; Pyridines; Rats; Rats, Sprague-Dawley; Tetrodotoxin; Vasoconstriction; Vasoconstrictor Agents | 2006 |
p38 mitogen-activated protein kinase mediates the sustained phase of hypoxic pulmonary vasoconstriction and plays a role in phase I vasodilation.
Topics: Animals; Anisomycin; Enzyme Activation; Enzyme Inhibitors; Hypoxia; Imidazoles; Isometric Contraction; Lung Diseases; Male; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Pulmonary Artery; Pyridines; Rats; Rats, Sprague-Dawley; Vasoconstriction; Vasodilation | 2006 |
Hindlimb unweighting induces changes in the p38MAPK contractile pathway of the rat abdominal aorta.
Topics: Adrenergic alpha-Agonists; Animals; Aorta, Abdominal; Butadienes; Disease Models, Animal; Enzyme Inhibitors; Hindlimb Suspension; HSP27 Heat-Shock Proteins; Imidazoles; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phorbol 12,13-Dibutyrate; Pyridines; Rats; Rats, Wistar; Signal Transduction | 2009 |
p38 Mitogen-activated protein kinase (MAPK) increases arginase activity and contributes to endothelial dysfunction in corpora cavernosa from angiotensin-II-treated mice.
Topics: Angiotensin II; Animals; Arginase; Blood Pressure; Electric Stimulation; Endothelium, Vascular; Enzyme Inhibitors; Imidazoles; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Nitric Oxide Synthase; p38 Mitogen-Activated Protein Kinases; Penis; Phenylephrine; Phosphorylation; Pyridines; Vasoconstrictor Agents | 2010 |
Cyclic AMP relaxation of rat aortic smooth muscle is mediated in part by decrease of depletion of intracellular Ca(2+) stores and inhibition of capacitative calcium entry.
Topics: Animals; Aorta, Thoracic; Calcium; Colforsin; Cyclic AMP; Imidazoles; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nifedipine; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Phosphodiesterase 4 Inhibitors; Pyridines; Rats; Rats, Inbred WKY; Rolipram; Vasodilation; Vasodilator Agents; Verapamil | 2013 |
Tumor suppressor gene ING3 induces cardiomyocyte hypertrophy via inhibition of AMPK and activation of p38 MAPK signaling.
Topics: AMP-Activated Protein Kinases; Angiotensin II; Animals; Animals, Newborn; Aorta, Abdominal; Cardiomegaly; Cell Membrane; Imidazoles; Isoproterenol; Male; MAP Kinase Signaling System; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Phenylephrine; Plasmids; Pyridines; Rats; Rats, Sprague-Dawley; RNA Interference; Tumor Suppressor Proteins | 2014 |